16-18 July 2018 | Boston
2 Weeks To Go!

Limited Passes Remaining – Secure Yours Now

Full Event Brochure Header

The 6th annual edition of the event series, Tumor Models Boston 2018 has been designed with input from thought leaders from over 40 biopharmaceutical organizations.

The meeting will provide new insights into the application of cutting edge in vitro, in vivo and in silico models, all to support your discovery programs from early-stage research to the patient.

Download the event guide to review full session details, the complete speaker line-up as well as a breakdown of the audience demographics and registration discounts.

Join peers to challenge, provoke and discuss key topics including:

  • Juno Therapeutics designing next generation immunotherapies developed through the state-of-the art in vitro, rodent and non human primate systems
  • Bellicium Pharmaceutical demonstrating the power of advanced in vitro assays to validate the efficacy and safety of CAR-based therapeutics for solid tumors
  • Eli Lilly showcasing their experimental and in silico efforts developing novel bi-specific antibodies with optimal affinity, valency, and structure while maintaining target cell binding

2018 Brochure Is Now Available!

“The conference was great. I enjoyed all the speakers and really enjoyed that the conference is very focused with all the right people in the room.” Abbott